Trials in Baltimore, Maryland
Here are the top 10 medical studies for prostate cancer in Baltimore, Maryland
Popular Filters
Phase 3 Trials
Radioisotope Therapy
177Lu-PSMA-I&T for Prostate Cancer
Recruiting2 awardsPhase 3
Baltimore, Maryland
This trial is testing a new radioactive drug against standard hormone therapy in men with advanced prostate cancer that doesn't respond to usual treatments. The drug targets and kills cancer cells using radiation. The drug being tested, 225Ac-PSMA-617, has shown promise in inducing complete responses in patients with metastatic castrate-resistant prostate cancer who were resistant to standard therapies.
Taxane
Capivasertib + Docetaxel for Prostate Cancer
Recruiting1 awardPhase 3
Baltimore, Maryland
This trial will compare the effect of two different treatments for metastatic prostate cancer. One group will receive a combination of capivasertib and docetaxel, while the other group will receive docetaxel and a placebo. The goal is to see if adding capivasertib to docetaxel improves survival rates.
Trials With No Placebo
Monoclonal Antibodies
REGN4336 + Cemiplimab for Prostate Cancer
Recruiting1 awardPhase 1 & 2
Baltimore, Maryland
This trial is testing a new cancer drug called REGN4336, alone or with other drugs, to see if it is safe and effective. It aims to help the immune system attack cancer cells. The study focuses on finding the right dose and understanding side effects.
Hormone Therapy
Testosterone + Enzalutamide for Prostate Cancer
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial will analyze the effects of oral testosterone therapy given on a schedule of seven days of therapy followed by seven days of no therapy for a 28 day cycle in men with metastatic castrate resistant prostate cancer.
Androgen Receptor Antagonist
ARV-766 +/- Abiraterone for Prostate Cancer
Recruiting1 awardPhase 1 & 2
Baltimore, Maryland
This trial is testing a new oral drug called ARV-766, alone or with abiraterone, in men with advanced prostate cancer that has spread. The drug works by blocking proteins that help cancer cells grow. Abiraterone is a well-established drug used in the treatment of metastatic castration-resistant prostate cancer, often in combination with other therapies.
Antiandrogen
Darolutamide + ADT for Metastatic Hormone-Sensitive Prostate Cancer
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial will test if adding darolutamide to ADT will be more effective than ADT alone in men with hormone-sensitive prostate cancer that has spread to other parts of the body.
Monoclonal Antibodies
Vudalimab for Advanced Gynecologic and Genitourinary Cancers
Recruiting1 awardPhase 2
Newark, Delaware
This trial is testing a new drug called vudalimab in patients with hard-to-treat advanced gynecologic and genitourinary cancers. The drug aims to boost the immune system's ability to fight cancer by making cancer cells more visible to immune cells.
Procedure
TULSA Procedure vs. Radical Prostatectomy for Prostate Cancer
Recruiting1 award6 criteria
Baltimore, Maryland
This trial compares a new treatment with traditional surgery in men with prostate cancer. The goal is to see if the new treatment can effectively treat cancer while preserving important functions better than surgery. Patients will be followed for several years to assess outcomes. The new treatment is minimally invasive and uses advanced technology to target prostate tissue.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.